J. Saucier

发表

Physicochemical studies on interactions between DNA and RNA polymerase. Unwinding of the DNA helix by Escherichia coli RNA polymerase

JAMES C. Wang, James C. Wang, J. Jacobsen, 1977 .

DNA ligase activity in crude extracts of fibroblasts and lymphocytes.

J. Saucier, F. Laval, 1983, Biochemical and biophysical research communications.

Angular alteration of the DNA helix by E. coli RNA polymerase.

J. Wang, J. Saucier, Jean-Marie Saucier, 1972, Nature: New biology.

Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon.

J. Saucier, M. Best-Belpomme, E. Nahon, 1993, European journal of biochemistry.

Genistein resistance in human leukaemic CCRF-CEM cells: selection of a diploid cell line with reduced DNA topoisomerase II beta isoform.

A. Bernheim, A. Jacquemin-Sablon, F. Goldwasser, 1995, Biochemical pharmacology.

Cellular resistance to the antitumor DNA topoisomerase II inhibitor S16020-2: importance of the N-[2(Dimethylamino)ethyl]carbamoyl side chain.

A. Jacquemin-Sablon, J. Markovits, J. Saucier, 2000, Molecular pharmacology.

Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.

A. Jacquemin-Sablon, J. Markovits, H. Jacquemin-Sablon, 1999, Cancer research.

Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.

A. Jacquemin-Sablon, J. Markovits, J. Le Pecq, 1989, Cancer research.

Mammalian DNA Topoisomerase II Inhibitory Effects of the Tyrosine Kinase Inhibitor Genistein on Updated

A. Jacquemin-Sablon, J. Markovits, A. Larsen, 2006 .

Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivatives.

A. Levitzki, E. Ségal-Bendirdjian, A. Jacquemin-Sablon, 1994, Biochemical pharmacology.

Physicochemical studies on the interaction of irehdiamine A with bihelical DNA.

J. Saucier, 1977, Biochemistry.

The change of the torsion of the DNA helix caused by intercalation. II. Measurement of the relative change of torsion induced by various intercalating drugs.

J. Le Pecq, B. Festy, J. Saucier, 1971, Biochimie.

In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1.

R. Kiss, C. Decaestecker, J. Fontaine, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

In Vitro and in Vivo Pharmacological Characterizations of the Antitumor Properties of Two New Olivacine Derivatives , S 16020-2 and S 30972-11

R. Kiss, C. Decaestecker, J. Fontaine, 2000 .

Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative.

C. Paoletti, P. Fossé, M. Le Bret, 1991, Nucleic acids research.

Enhanced topoisomerase II-induced DNA breaks and free radical production by a new anthracycline with potent antileukemic activity.

C. Monneret, J. Florent, C. Auclair, 1996, Leukemia research.

Stimulation of site-specific topoisomerase II-mediated DNA cleavage by an N-methylpyrrolecarboxamide-anilinoacridine conjugate: relation to DNA binding.

M. Waring, C. Bailly, P. Colson, 1994, Biochemistry.

Stimulation by γ-carboline derivatives (simplified analogues of antitumor ellipticines) of site specific DNA cleavage by calf DNA topoisomerase II

C. Nguyen, C. Paoletti, P. Fossé, 1990 .

S16020-2, a new highly cytotoxic antitumor olivacine derivative: DNA interaction and DNA topoisomerase II inhibition.

A. Jacquemin-Sablon, J. Markovits, A. Pierré, 1998, Molecular pharmacology.

DNA filter retention assay for exonuclease activities. Application to the analysis of processivity of phage T5 induced 5'-exonuclease.

A. Jacquemin-Sablon, M. Joannes, J. Saucier, 1985, Biochemistry.

A carboline derivative as a novel mammalian DNA topoisomerase II targeting agent.

F. Pognan, C. Paoletti, L. Kaczmarek, 1992, Biochemical pharmacology.

Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activities.

C. Nguyen, A. Larsen, J. Riou, 1993, Cancer research.

DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives.

J. Belehradek, O. Mauffret, M. Monnot, 1991, The Journal of biological chemistry.

Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.

P. Gros, C. Paoletti, C. Auclair, 1987, Cancer research.

Biological activity and molecular interaction of a netropsin-acridine hybrid ligand with chromatin and topoisomerase II.

C. Bailly, P. Colson, C. Fournier, 1992, Biochemical pharmacology.

Characterization of the molecular components in kinetoplast- mitochondrial DNA of Trypanosoma equiperdum. Comparative study of the dyskinetoplastic and wild strains

G. Riou, J. Saucier, 1979, The Journal of cell biology.

Characterization by sedimentation analysis of kinetoplast DNA from Trypanosoma cruzi at different stages of culture.

G. Riou, J. Saucier, J. Bénard, 1979, Nucleic acids research.

Reduced DNA topoisomerase II activity and drug-stimulated DNA cleavage in 9-hydroxyellipticine resistant cells.

A. Jacquemin-Sablon, J. Charcosset, J. Saucier, 1988, Biochemical pharmacology.

Occurrence of a kinetoplast DNA-protein complex in Trypanosoma cruzi.

J. da Silva, G. Riou, J. Saucier, 1981, Biochemical and biophysical research communications.

Structural changes of polyriboinosinic acid induced by a steroidal diamine, irehdiamine A.

C. Paoletti, J. Saucier, P. Lefresne, 1967, Biochemical and biophysical research communications.

A CD study of interactions of ellipticine derivatives with DNA

J. Belehradek, O. Mauffret, M. Monnot, 1990, FEBS letters.

Selective retention of double-stranded circular deoxyribonucleic acid by membrane filtration.

J. Saucier, J. Wang, 1973, Biochemistry.

Pattern of recognition of DNA by mammalian DNA topoisomerase II.

C. Paoletti, P. Fossé, J. Saucier, 1988, Biochemical and biophysical research communications.

Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship.

C. Paoletti, P. Fossé, J. Saucier, 1992, Molecular pharmacology.

Relationships between physicochemical and biological properties in a series of oxazolopyridocarbazole derivatives (OPCd); comparison with related anti-tumor agents.

H. Banoun, A. Larsen, C. Auclair, 1988, Anti-cancer drug design.

Characterization of the molecular components in kinetoplast- mitochondrial DNA of Trypanosoma equiperdum. Comparative study of the dyskinetoplastic and wild strains

G. Riou, J. Saucier, 1979, The Journal of cell biology.